These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 24953854)
1. Dexamethasone inhibits in vivo tumor growth by the alteration of bone marrow CD11b⁺ myeloid cells. Moon EY; Ryu YK; Lee GH Int Immunopharmacol; 2014 Aug; 21(2):494-500. PubMed ID: 24953854 [TBL] [Abstract][Full Text] [Related]
2. miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells. Liu Q; Zhang M; Jiang X; Zhang Z; Dai L; Min S; Wu X; He Q; Liu J; Zhang Y; Zhang Z; Yang R Int J Cancer; 2011 Dec; 129(11):2662-73. PubMed ID: 21213211 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. Varga G; Ehrchen J; Tsianakas A; Tenbrock K; Rattenholl A; Seeliger S; Mack M; Roth J; Sunderkoetter C J Leukoc Biol; 2008 Sep; 84(3):644-50. PubMed ID: 18611985 [TBL] [Abstract][Full Text] [Related]
5. Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide. Liao J; Wang X; Bi Y; Shen B; Shao K; Yang H; Lu Y; Zhang Z; Chen X; Liu H; Wang J; Chu Y; Xue L; Wang X; Liu G J Leukoc Biol; 2014 Nov; 96(5):675-84. PubMed ID: 24948701 [TBL] [Abstract][Full Text] [Related]
6. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314 [TBL] [Abstract][Full Text] [Related]
7. Immature myeloid Gr-1+ CD11b+ cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function. Landoni VI; Martire-Greco D; Rodriguez-Rodrigues N; Chiarella P; Schierloh P; Isturiz MA; Fernández GC Clin Sci (Lond); 2016 Feb; 130(4):259-71. PubMed ID: 26582821 [TBL] [Abstract][Full Text] [Related]
8. Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus. Clements DR; Sterea AM; Kim Y; Helson E; Dean CA; Nunokawa A; Coyle KM; Sharif T; Marcato P; Gujar SA; Lee PW J Immunol; 2015 May; 194(9):4397-412. PubMed ID: 25825443 [TBL] [Abstract][Full Text] [Related]
9. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Yang R; Cai Z; Zhang Y; Yutzy WH; Roby KF; Roden RB Cancer Res; 2006 Jul; 66(13):6807-15. PubMed ID: 16818658 [TBL] [Abstract][Full Text] [Related]
10. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo. Hegde VL; Singh UP; Nagarkatti PS; Nagarkatti M J Immunol; 2015 Jun; 194(11):5211-22. PubMed ID: 25917103 [TBL] [Abstract][Full Text] [Related]
11. Angiogenesis following cell injection is induced by an excess inflammatory response coordinated by bone marrow cells. Hattori H; Amano Y; Habu-Ogawa Y; Ando T; Takase B; Ishihara M Cell Transplant; 2013; 22(12):2381-92. PubMed ID: 23146336 [TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas. Furudate S; Fujimura T; Kambayashi Y; Kakizaki A; Hidaka T; Aiba S Anticancer Res; 2017 Jul; 37(7):3461-3471. PubMed ID: 28668835 [TBL] [Abstract][Full Text] [Related]
13. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro. Han EC; Lee J; Ryu SW; Choi C Biochem Biophys Res Commun; 2014 Jan; 443(4):1218-25. PubMed ID: 24388986 [TBL] [Abstract][Full Text] [Related]
14. Acceleration of collateral development by carcinoembryonic antigen-related cell adhesion molecule 1 expression on CD11b/⁺Gr-1⁺ myeloid cells--brief report. Bickert T; Marshall RP; Zhang Z; Ludewig P; Binder M; Klinke A; Rottbauer W; Amling M; Wagener C; Ito WD; Horst AK Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2566-8. PubMed ID: 22962327 [TBL] [Abstract][Full Text] [Related]
15. Hematopoietic growth factors and glucocorticoids synergize to mimic the effects of IL-1 on granulocyte differentiation and IL-1 receptor induction on bone marrow cells in vivo. Dubois CM; Neta R; Keller JR; Jacobsen SE; Oppenheim JJ; Ruscetti F Exp Hematol; 1993 Feb; 21(2):303-10. PubMed ID: 7678814 [TBL] [Abstract][Full Text] [Related]
16. Effect of mild hypothermia on the increase of CD11b+ Gr-1+ myeloid-derived suppressor cells induced by lipopolysaccharide in a mouse model of sepsis. Li X; Liu L; Luo F; Gui L; Fan D; Xie Q Am J Emerg Med; 2015 Oct; 33(10):1430-5. PubMed ID: 26275630 [TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors. Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342 [TBL] [Abstract][Full Text] [Related]
18. CD11b+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation. Serra AM; Waddell J; Manivannan A; Xu H; Cotter M; Forrester JV Am J Pathol; 2012 Aug; 181(2):719-27. PubMed ID: 22677420 [TBL] [Abstract][Full Text] [Related]
19. Areca nut extracts enhance the development of CD11b(+) Gr-1(+) cells with the characteristics of myeloid-derived suppressor cells in antigen-stimulated mice. Wang CC; Lin HL; Liang HJ; Jan TR J Oral Pathol Med; 2011 Nov; 40(10):769-77. PubMed ID: 21481006 [TBL] [Abstract][Full Text] [Related]
20. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow. Poh TW; Bradley JM; Mukherjee P; Gendler SJ Cancer Res; 2009 Apr; 69(8):3554-62. PubMed ID: 19351842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]